Cardiac troponins: what we knew, what we know – where are we now?

Artikel in diesem Heft

1. Editorial
2. Cardiac troponins: what we knew, what we know – where are we now?
3. Review
4. Measurement of circulating concentrations of cardiac troponin I and T in healthy subjects: a tool for monitoring myocardial tissue renewal?
5. Opinion Papers
6. A critical appraisal of experimental factors influencing the definition of the 99th percentile limit for cardiac troponins
7. Genetic and biochemical heterogeneity of cardiac troponins: clinical and laboratory implications
8. The future of hospital laboratories. Position statement from the Royal Belgian Society of Clinical Chemistry (RBSCC)
9. Point
10. Quantity quotient reporting. A proposal for a standardized presentation of laboratory results
11. Counterpoint
12. Quantity quotient reporting. Counterpoint
13. Perspectives
14. Increasing laboratory medicine activities in China: research and publications
15. Contributions in Biochemistry and Molecular Biology from China and other top-ranking countries: a 10-year survey of the literature
16. Genetics and Molecular Diagnostics
17. SOCS3 and IRS-1 gene expression differs between genotype 1 and genotype 2 hepatitis C virus-infected HepG2 cells
18. Polymorphisms of the β1-adrenergic receptor gene are associated with essential hypertension in Chinese
19. Egyptian glycogen storage disease type III – identification of six novel AGL mutations, including a large 1.5 kb deletion and a missense mutation p.L620P with subtype IIId
20. Novel rare alleles of ABCA1 are exclusively associated with extreme high-density lipoprotein-cholesterol levels among the Han Chinese
21. –308G>A and –1031T>C tumor necrosis factor gene polymorphisms in Tunisian patients with coronary artery disease
22. General Clinical Chemistry and Laboratory Medicine
23. Error tracking in a clinical biochemistry laboratory
24. HbA1c measurements from dried blood spots: validation and patient satisfaction
25. Pre-transplant serum concentrations of anti-endothelial cell antibody in panel reactive antibody negative renal recipients and its impact on acute rejection
26. Cancer Diagnostics
27. Detection of Meningeosis neoplastica by real-time quantitation of telomerase activity
28. The prognostic utility of haptoglobin genotypes in squamous cell carcinoma of the head and neck
29. Evaluation of a new method for the diagnosis of alterations of Lens culinaris agglutinin binding of thyroglobulin molecules in thyroid carcinoma
30. The soluble transferrin receptor (TfR)-F-Index is not applicable as a test for iron status in patients with chronic lymphocytic leukemia
31. Impact of calibration fitting models on the clinical value of chromogranin A
32. Letters to the Editor
33. Clinical value of a competitive NT-proBNP enzyme immunoassay compared to the Roche NT-proBNP platform
34. Should gender-related reference values be used for total bilirubin?
35. A novel nonsense mutation in the albumin gene (c.1275 C>A) causing analbuminemia in a Tunisian boy
36. Abstracts
37. 41^st National Congress of the Italian Society of Clinical Biochemistry and Clinical Molecular Biology, 2nd Joint National Event SIBioC-SIMeL